Article
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
2023-06-29
Abstract excerpt
<title>Abstract</title> <p>Allogeneic hematopoietic cell transplantation (allo-HCT) is curative for myelofibrosis (MF) but assessing risk-benefit in individual patients is challenging. This complexity is amplified in <italic>CALR-</italic>mutated MF patients, as they live longer with conventional treatments compared to other molecular subtypes. We analyzed outcomes of 346 <italic>CALR</italic>-mutated MF patients...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1d0adc7-8287-56dc-9428-11a332ccdc3b
- DOI
- 10.21203/rs.3.rs-3108004/v1
